MLchartDataset catalogue

VAdriaC-IE regimen

Term · Oncology and biomedicine · MLC-T-ONC-009137

An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide, followed by ifosfamide and etoposide phosphate. Also called VAC-IE, VAC-IE regimen, and VAdriaC-IE.

Table 1. Record
IdentifierMLC-T-ONC-009137
FieldOncology and biomedicine
SynonymsVAC-IE; VAC-IE regimen; VAdriaC-IE
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009137",
  "term": "VAdriaC-IE regimen",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide, followed by ifosfamide and etoposide phosphate. Also called VAC-IE, VAC-IE regimen, and VAdriaC-IE.",
  "synonyms": [
    "VAC-IE",
    "VAC-IE regimen",
    "VAdriaC-IE"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/vadriac-ie-regimen/"
}

Record 17,068 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.